Skip to main content
PMC home page
Journal of Medical Ethics logoLink to Journal of Medical Ethics
. 2005 Jul;31(7):393–398. doi: 10.1136/jme.2004.008219

Newborn screening: new developments, new dilemmas

N Kerruish 1, S Robertson 1
PMCID: PMC1734185  PMID: 15994357

Full Text

The Full Text of this article is available as a PDF (76.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baird P. A. Genetics and health care: a paradigm shift. Perspect Biol Med. 1990 Winter;33(2):203–213. doi: 10.1353/pbm.1990.0009. [DOI] [PubMed] [Google Scholar]
  2. Barker Jennifer M., Goehrig Stephanie H., Barriga Katherine, Hoffman Michelle, Slover Robert, Eisenbarth George S., Norris Jill M., Klingensmith Georgeanna J., Rewers Marian, DAISY study Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care. 2004 Jun;27(6):1399–1404. doi: 10.2337/diacare.27.6.1399. [DOI] [PubMed] [Google Scholar]
  3. Beauchamp T. L. Methods and principles in biomedical ethics. J Med Ethics. 2003 Oct;29(5):269–274. doi: 10.1136/jme.29.5.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bennett Johnson Suzanne, Baughcum Amy E., Carmichael Stacy K., She Jin-Xiong, Schatz Desmond A. Maternal anxiety associated with newborn genetic screening for type 1 diabetes. Diabetes Care. 2004 Feb;27(2):392–397. doi: 10.2337/diacare.27.2.392. [DOI] [PubMed] [Google Scholar]
  5. Clarke A. The genetic testing of children. Working Party of the Clinical Genetics Society (UK) J Med Genet. 1994 Oct;31(10):785–797. doi: 10.1136/jmg.31.10.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davidson-Rada J., Caldis S., Tonkin S. L. New Zealand's SIDS prevention program and reduction in infant mortality. Health Educ Q. 1995 May;22(2):162–171. doi: 10.1177/109019819502200205. [DOI] [PubMed] [Google Scholar]
  7. Davison Charlie, Macintyre Sally, Smith George Davey. The potential social impact of predictive genetic testing for susceptibility to common chronic diseases: a review and proposed research agenda. Sociol Health Illn. 1994 Jun;16(3):340–371. doi: 10.1111/1467-9566.ep11348762. [DOI] [PubMed] [Google Scholar]
  8. Devendra Devasenan, Liu Edwin, Eisenbarth George S. Type 1 diabetes: recent developments. BMJ. 2004 Mar 27;328(7442):750–754. doi: 10.1136/bmj.328.7442.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dhanda Rahul K., Reilly Philip R. Legal and ethical issues of newborn screening. Pediatr Ann. 2003 Aug;32(8):540–546. doi: 10.3928/0090-4481-20030801-11. [DOI] [PubMed] [Google Scholar]
  10. Fyrö K., Bodegård G. Four-year follow-up of psychological reactions to false positive screening tests for congenital hypothyroidism. Acta Paediatr Scand. 1987 Jan;76(1):107–114. doi: 10.1111/j.1651-2227.1987.tb10424.x. [DOI] [PubMed] [Google Scholar]
  11. GUTHRIE R., SUSI A. A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. Pediatrics. 1963 Sep;32:338–343. [PubMed] [Google Scholar]
  12. Greener M. PANDA identifies babies at risk of developing type 1 diabetes. Mol Med Today. 2000 Jan;6(1):3–3. doi: 10.1016/s1357-4310(99)01625-1. [DOI] [PubMed] [Google Scholar]
  13. Hall D. M., Michel J. M. Screening in infancy. Arch Dis Child. 1995 Jan;72(1):93–96. doi: 10.1136/adc.72.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Holtzman N. A., Marteau T. M. Will genetics revolutionize medicine? N Engl J Med. 2000 Jul 13;343(2):141–144. doi: 10.1056/NEJM200007133430213. [DOI] [PubMed] [Google Scholar]
  15. Hulley S. B., Newman T. B. Position statement: cholesterol screening in children is not indicated, even with positive family history. J Am Coll Nutr. 1992 Jun;11 (Suppl):20S–22S. doi: 10.1080/07315724.1992.10737978. [DOI] [PubMed] [Google Scholar]
  16. Kimpimäki T., Kupila A., Hämäläinen A. M., Kukko M., Kulmala P., Savola K., Simell T., Keskinen P., Ilonen J., Simell O. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. J Clin Endocrinol Metab. 2001 Oct;86(10):4782–4788. doi: 10.1210/jcem.86.10.7907. [DOI] [PubMed] [Google Scholar]
  17. Kupila A., Muona P., Simell T., Arvilommi P., Savolainen H., Hämäläinen A. M., Korhonen S., Kimpimäki T., Sjöroos M., Ilonen J. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia. 2001 Mar;44(3):290–297. doi: 10.1007/s001250051616. [DOI] [PubMed] [Google Scholar]
  18. Laugesen Murray, Elliott Robert. Ischaemic heart disease, Type 1 diabetes, and cow milk A1 beta-casein. N Z Med J. 2003 Jan 24;116(1168):U295–U295. [PubMed] [Google Scholar]
  19. Levy Harvey L. Lessons from the past--looking to the future. Newborn screening. Pediatr Ann. 2003 Aug;32(8):505–508. doi: 10.3928/0090-4481-20030801-07. [DOI] [PubMed] [Google Scholar]
  20. Marteau T. M., Croyle R. T. The new genetics. Psychological responses to genetic testing. BMJ. 1998 Feb 28;316(7132):693–696. doi: 10.1136/bmj.316.7132.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Marteau T. M., van Duijn M., Ellis I. Effects of genetic screening on perceptions of health: a pilot study. J Med Genet. 1992 Jan;29(1):24–26. doi: 10.1136/jmg.29.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mathew C. Science, medicine, and the future: Postgenomic technologies: hunting the genes for common disorders. BMJ. 2001 Apr 28;322(7293):1031–1034. doi: 10.1136/bmj.322.7293.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Meador C. K. The last well person. N Engl J Med. 1994 Feb 10;330(6):440–441. doi: 10.1056/NEJM199402103300618. [DOI] [PubMed] [Google Scholar]
  24. Paronen J., Knip M., Savilahti E., Virtanen S. M., Ilonen J., Akerblom H. K., Vaarala O. Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. Diabetes. 2000 Oct;49(10):1657–1665. doi: 10.2337/diabetes.49.10.1657. [DOI] [PubMed] [Google Scholar]
  25. Parsons E. P., Clarke A. J., Hood K., Lycett E., Bradley D. M. Newborn screening for Duchenne muscular dystrophy: a psychosocial study. Arch Dis Child Fetal Neonatal Ed. 2002 Mar;86(2):F91–F95. doi: 10.1136/fn.86.2.F91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pollitt R. J., Green A., McCabe C. J., Booth A., Cooper N. J., Leonard J. V., Nicholl J., Nicholson P., Tunaley J. R., Virdi N. K. Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess. 1997;1(7):i-iv, 1-202. [PubMed] [Google Scholar]
  27. Rewers M., Bugawan T. L., Norris J. M., Blair A., Beaty B., Hoffman M., McDuffie R. S., Jr, Hamman R. F., Klingensmith G., Eisenbarth G. S. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia. 1996 Jul;39(7):807–812. doi: 10.1007/s001250050514. [DOI] [PubMed] [Google Scholar]
  28. Robertson S., Savulescu J. Is there a case in favour of predictive genetic testing in young children? Bioethics. 2001 Feb;15(1):26–49. doi: 10.1111/1467-8519.00210. [DOI] [PubMed] [Google Scholar]
  29. Rønningen K. S. Genetics in the prediction of insulin-dependent diabetes mellitus: from theory to practice. Ann Med. 1997 Oct;29(5):387–392. doi: 10.3109/07853899708999367. [DOI] [PubMed] [Google Scholar]
  30. Seymour C. A., Thomason M. J., Chalmers R. A., Addison G. M., Bain M. D., Cockburn F., Littlejohns P., Lord J., Wilcox A. H. Newborn screening for inborn errors of metabolism: a systematic review. Health Technol Assess. 1997;1(11):i-iv, 1-95. [PubMed] [Google Scholar]
  31. Sorenson J. R., Levy H. L., Mangione T. W., Sepe S. J. Parental response to repeat testing of infants with 'false-positive' results in a newborn screening program. Pediatrics. 1984 Feb;73(2):183–187. [PubMed] [Google Scholar]
  32. Streetly A., Grant C., Pollitt R. J., Addison G. M. Survey of scope of neonatal screening in the United Kingdom. BMJ. 1995 Sep 16;311(7007):726–726. doi: 10.1136/bmj.311.7007.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Thelin T., McNeil T. F., Aspegren-Jansson E., Sveger T. Psychological consequences of neonatal screening for alpha 1-antitrypsin deficiency. Parental reactions to the first news of their infants' deficiency. Acta Paediatr Scand. 1985 Sep;74(5):787–793. doi: 10.1111/j.1651-2227.1985.tb10032.x. [DOI] [PubMed] [Google Scholar]
  34. Thomasgard M., Metz W. P. The vulnerable child syndrome revisited. J Dev Behav Pediatr. 1995 Feb;16(1):47–53. [PubMed] [Google Scholar]
  35. Wald N. J., Morris J. K. Neonatal screening for cystic fibrosis. BMJ. 1998 Feb 7;316(7129):404–405. doi: 10.1136/bmj.316.7129.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Webb S. J., Monk C. S., Nelson C. A. Mechanisms of postnatal neurobiological development: implications for human development. Dev Neuropsychol. 2001;19(2):147–171. doi: 10.1207/S15326942DN1902_2. [DOI] [PubMed] [Google Scholar]
  37. al-Jader L. N., Goodchild M. C., Ryley H. C., Harper P. S. Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis. Clin Genet. 1990 Dec;38(6):460–465. doi: 10.1111/j.1399-0004.1990.tb03613.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Ethics are provided here courtesy of BMJ Publishing Group

RESOURCES